Search Treatments A to Z

    • MARCH 26, 2025
    • 0
    PSMA PET/CT Scan – The Future of Prostate Cancer Detection and Treatment

    PSMA PET/CT Scan – The Future of Prostate Cancer Detection and Treatment

    Discover how the cutting-edge PSMA PET/CT scan is changing prostate cancer imaging and treatment. Learn about the £2M UK trial and how it could save lives. PSMA PET scan, prostate cancer imaging, advanced prostate cancer detection, PSMA scan trial, prostate cancer PET/CT scan Introduction: A Game-Changer in Prostate Cancer Diagnosis If you or someone you

    • MARCH 12, 2025
    • 0
    Talazoparib and Enzalutamide – A New Hope for Advanced Prostate Cancer

    Talazoparib and Enzalutamide – A New Hope for Advanced Prostate Cancer

    Prostate cancer is one of the most prevalent cancers among men, impacting millions worldwide. While treatments have evolved over the years, advanced prostate cancer remains challenging to manage. However, a recent breakthrough in therapy is offering new hope—Talazoparib in combination with Enzalutamide. This newly approved treatment option provides an innovative approach to targeting prostate cancer,

    • OCTOBER 2, 2024
    • 0
    Advances and Innovations in Prostate Cancer Treatments

    Advances and Innovations in Prostate Cancer Treatments

    Prostate cancer remains one of the most common malignancies affecting men worldwide. Over the last 50 years, significant advancements in research and technology have revolutionized the landscape of prostate cancer treatment. In the 1970s, options were limited primarily to radical prostatectomy and external beam radiation therapy, often with a standardized approach that did not account

    • OCTOBER 2, 2024
    • 0
    Rethinking Prostate Cancer: The Push to Rebrand Low-Grade Cases

    Rethinking Prostate Cancer: The Push to Rebrand Low-Grade Cases

    Recent discussions among urologists suggest that rebranding low-grade prostate cancer could alleviate the anxiety patients experience upon diagnosis. Prostate cancer, notably common among men, often presents in low-grade forms that are typically slow-growing and unlikely to lead to severe health issues. This initiative aims to reduce overtreatment stemming from the fear associated with the “cancer”